Detailed immunophenotypic and genetic characterization of bone marrow clonal plasma cells and B-cells in early-stage monoclonal gammopathies
Open Access
- 18 July 2026
- journal article
- research article
- Published by Springer Nature in Blood Cancer Journal
- Vol. 16 (1)
Abstract
Monoclonal gammopathy (MG) of undetermined significance (MGUS) is the earliest and most prevalent stage of MG that may progress to symptomatic multiple myeloma (MM) or Waldenström’s macroglobulinemia (WM) through intermediate smoldering forms of both diseases. We used next-generation flow cytometry (NGF) to identify and purify bone marrow (BM) clonal plasma cells (cPC) and B-cells/lymphoplasmacytic cells (cB-cells) from 25 asymptomatic individuals with MG diagnosed within the population-based iStopMM screening program for further molecular analysis by next-generation sequencing (NGS). IgM-MGUS cases consistently exhibited WM-like phenotypes by NGF, and MYD88 p.L265P and/or CXCR4 mutations in the coexisting cPC and cB-cells. Conversely, cPC from non-IgM MGUS and smoldering MM (SMM) displayed a MM-like phenotype associated with genetic drivers –i.e., t(11;14)–, frequently coexisting with genetically unrelated cB-cells. Interestingly, recurrent RUNX1 single nucleotide variants were detected in cPC, but not coexisting cB-cells, from WM-like cases, suggesting a role for RUNX1 in PC differentiation. In summary, NGF enabled detailed immunophenotypic characterization of BM cPC and cB-cell populations in all cases analyzed, subdivided in IgM vs non-IgM cases with WM-like or MM-like phenotypic and genetic profiles, respectively. These findings underscore the potential contribution of NGF and NGS for accurate classification or early-stage disease, beyond conventional criteria.Keywords
Funding Information
- Consejería de Educación, Junta de Castilla y León (Orden EDU/601/2020)
This publication has 55 references indexed in Scilit:
- Waldenström Macroglobulinemia: 2025 Update on Diagnosis, Risk Stratification, and ManagementAmerican Journal of Hematology, 2025
- Mutational Landscape of Bone Marrow CD19 and CD138 Cells in Waldenström Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM MGUS)Cancer Medicine, 2024
- Monoclonal gammopathy of undetermined significance with multiple paraproteins: A population‐based screening studyHemaSphere, 2024
- Prognostic risk and survival of asymptomatic IgM monoclonal gammopathy: Results from a Spanish Multicenter RegistryHemaSphere, 2024
- Multiple myeloma: 2024 update on diagnosis, risk‐stratification, and managementAmerican Journal of Hematology, 2024
- Immunoglobulin Gene Mutational Status Assessment by Next Generation Sequencing in Chronic Lymphocytic Leukemia2022
- Flow cytometric immunophenotyping of plasma cells across the spectrum of plasma cell proliferative disorders: A fresh insight with pattern‐based recognitionCytometry Part B: Clinical Cytometry, 2022
- Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications forMRDdetection in multiple myelomaCytometry Part B: Clinical Cytometry, 2015
- Immunophenotypic analysis reveals heterogeneity and common biologic aspects in monoclonal B‐cell lymphocytosisGenes, Chromosomes and Cancer, 2014
- Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell‐related disordersCytometry Part B: Clinical Cytometry, 2010